AACE released clinical guidelines on the diagnosis, management, and surveillance of tumors related to multiple endocrine ...

For adults with diabetes and obesity, GLP-1 RAs are associated with a reduced risk for obesity-related cancer compared with DPP-4 inhibitors.

Spinal cord stimulation can reduce pain and restore nerve function among patients with diabetic peripheral neuropathy.

Compounded vs non-compounded GLP-1 RA drug products are associated with an increased risk for adverse events such as nausea and diarrhea.

AI-assisted insulin titration was noninferior to endocrinologists in managing glycemic control among patients with type 2 diabetes.

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Certain air pollutants were associated with changes in metabolites among postmenopausal women in the US, potentially impacting bone health.

Early-life risk factors including lack of breastfeeding and low birth weight were associated with increased risk for adult-onset type 2 diabetes.

High-dose HCQ use may lower the risk for diabetes among patients with pSS and can potentially mitigate the diabetogenic effects of glucocorticoids.

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.

A new White House report says today’s children are the sickest generation in U.S. history when it comes to chronic disease.